This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
The benefits of DLBS3233 treatment in subjects with prediabetes
This page is a summary of: Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa, Drug Design Development and Therapy, March 2016, Dove Medical Press,
DOI: 10.2147/dddt.s97568.
You can read the full text:
The following have contributed to this page
Current Pharmaceutical Analysis
Trimetazidine and metoprolol combinations can be easily analyzed by HPTLC method developed here. The method development by HPTLC and subsequently validation is been discussed.
Journal of Pharmacy Practice
This article provides a step-by-step guide on creating a high-impact student-centered, active learning experience. The approach described transforms principles of education science into applicable ...
Current Cancer Therapy Reviews
There is sufficient evidence of the role of maintaining good nutritional status during pregnancy, the first year of life and childhood. Nutritional and environmental risk factors such as having a g...
